CV Sciences, Inc. Reports Growing Clinical Evidence for Therapeutic Value of Pharmaceutical-Grade Cannabidiol (CBD) Jul 5, 2017
CV Sciences, Inc. to Exhibit and Present at the American Association of Naturopathic Physicians 2017 National Conference Jun 27, 2017
CV Sciences, Inc.'s CEO Releases Letter to Stockholders and Customers Regarding Complaint filed by Securities and Exchange Commission Jun 19, 2017
CV Sciences, Inc. Announces Commencement of IND preparation immediately following Pre-IND Meeting With FDA Jun 19, 2017
CV Sciences, Inc. Applauds U.S. Department of Defense Smokeless Tobacco Cessation Campaign Mar 22, 2017